ChromaDex Corporation (CDXC) Reaches New 12-Month High at $5.71
Shares of ChromaDex Corporation (NASDAQ:CDXC) hit a new 52-week high during trading on Monday . The company traded as high as $5.71 and last traded at $5.31, with a volume of 658800 shares traded. The stock had previously closed at $4.89.
A number of analysts have recently commented on the company. Zacks Investment Research cut ChromaDex Corporation from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 15th. ValuEngine raised ChromaDex Corporation from a “sell” rating to a “hold” rating in a research report on Friday, September 8th. HC Wainwright set a $5.00 price target on ChromaDex Corporation and gave the stock a “buy” rating in a research report on Friday, August 11th. Finally, Ladenburg Thalmann Financial Services assumed coverage on ChromaDex Corporation in a research report on Monday, September 25th. They issued a “buy” rating and a $7.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $6.33.
The company has a current ratio of 5.03, a quick ratio of 4.12 and a debt-to-equity ratio of 0.01.
In related news, major shareholder Step Holdings Ltd Pioneer purchased 786,167 shares of the company’s stock in a transaction dated Friday, August 18th. The shares were purchased at an average cost of $2.60 per share, with a total value of $2,044,034.20. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 11.59% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. raised its holdings in ChromaDex Corporation by 870.6% in the 2nd quarter. Goldman Sachs Group Inc. now owns 182,633 shares of the company’s stock worth $698,000 after acquiring an additional 163,817 shares during the last quarter. North Star Investment Management Corp. raised its holdings in ChromaDex Corporation by 78.9% in the 2nd quarter. North Star Investment Management Corp. now owns 265,334 shares of the company’s stock worth $1,014,000 after acquiring an additional 117,000 shares during the last quarter. LMR Partners LLP purchased a new position in ChromaDex Corporation in the 2nd quarter worth approximately $347,000. Bank of Montreal Can purchased a new position in ChromaDex Corporation in the 2nd quarter worth approximately $168,000. Finally, Thompson Davis & CO. Inc. purchased a new position in ChromaDex Corporation in the 3rd quarter worth approximately $128,000. Institutional investors own 8.00% of the company’s stock.
TRADEMARK VIOLATION WARNING: “ChromaDex Corporation (CDXC) Reaches New 12-Month High at $5.71” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/chromadex-corporation-cdxc-reaches-new-12-month-high-at-5-71/1704192.html.
About ChromaDex Corporation
Chromadex Corporation and its subsidiaries ChromaDex, Inc, ChromaDex Analytics, Inc and Spherix Consulting, Inc provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets.
Receive News & Ratings for ChromaDex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChromaDex Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.